1. Home
  2. Detail

@mintrietriviu: Kẹo Mybacin Zinc Plus nhon nhonn đỉnn đinnn#xuhuong #TikTokShop1111 #SaleToVoDoi #ancungtiktok #anvat

À Nhon Daily
À Nhon Daily
Open In TikTok:
Region: VN
Saturday 07 November 2026 16:46:04 GMT
46948
206
1
18

Music

Download

No Watermark .mp4 (6.18MB) Watermark .mp4 (6.5MB) Music .mp3

Comments

minhlavannn_
minhlavannn_ :
b ơi cho mình xin contact nha
2026-11-07 16:57:08
0
To see more videos from user @mintrietriviu, please go to the Tikwm homepage.

Other Videos

Trả lời @Tui Trân Đây Chi phí để làm Hệ tủ quần áo và lan can gỗ cho căn hộ nhỏ 21m2
Trả lời @Tui Trân Đây Chi phí để làm Hệ tủ quần áo và lan can gỗ cho căn hộ nhỏ 21m2
Tuto henna du jour ✨ #henna #hennadesign #tuto
Tuto henna du jour ✨ #henna #hennadesign #tuto
#eyebrowmascara #saceladytintedbrowgel #browgel #fluffybrows #waterproofbrowgel
#eyebrowmascara #saceladytintedbrowgel #browgel #fluffybrows #waterproofbrowgel


___
___"Jika Allah telah menaikkan rezeki mu, jangan naikkan gaya hidup mu. Tapi naikkan lah sedekah mu___"#fypシ #katakata #quotes #story #motivasihidup
The nitty-gritty on Giredestrant 👇 It's a daily pill that blocks the estrogen receptor and signals the cell to break it down. Tamoxifen blocks it. Aromatase inhibitors lower estrogen. This tries to remove the receptor. Trial: 4,170 people with early-stage ER-positive, HER2-negative breast cancer. It cut the risk of invasive recurrence or death by 30% vs standard hormone therapy. At 3 years, 92.4% vs 89.6% were alive and free of invasive disease. Overall survival data are still immature. It's also being studied in advanced disease. Side effects: joint pain 46.5% vs 45.3%, hot flashes 27.1% vs 28.5%, headache 15.2% vs 13.1%, so those were similar in both groups. Slower heart rate was higher, 11.3% vs 3.2%, mostly mild with no symptoms. Fewer stopped treatment, 5.3% vs 8.2%. FDA decision expected November 30 for early-stage ER-positive, HER2-negative breast cancer. A separate advanced application is also under review. It hasn't replaced standard therapy, and it's not right for everyone. Information only, not medical advice. If you're ER-positive, ask your oncologist about it. Have you heard of this? Tell us in the comments anything I missed. #breastcancer #BreastCancerAwareness #cancersucks #fuckcancer #bionicmomrebuilds
The nitty-gritty on Giredestrant 👇 It's a daily pill that blocks the estrogen receptor and signals the cell to break it down. Tamoxifen blocks it. Aromatase inhibitors lower estrogen. This tries to remove the receptor. Trial: 4,170 people with early-stage ER-positive, HER2-negative breast cancer. It cut the risk of invasive recurrence or death by 30% vs standard hormone therapy. At 3 years, 92.4% vs 89.6% were alive and free of invasive disease. Overall survival data are still immature. It's also being studied in advanced disease. Side effects: joint pain 46.5% vs 45.3%, hot flashes 27.1% vs 28.5%, headache 15.2% vs 13.1%, so those were similar in both groups. Slower heart rate was higher, 11.3% vs 3.2%, mostly mild with no symptoms. Fewer stopped treatment, 5.3% vs 8.2%. FDA decision expected November 30 for early-stage ER-positive, HER2-negative breast cancer. A separate advanced application is also under review. It hasn't replaced standard therapy, and it's not right for everyone. Information only, not medical advice. If you're ER-positive, ask your oncologist about it. Have you heard of this? Tell us in the comments anything I missed. #breastcancer #BreastCancerAwareness #cancersucks #fuckcancer #bionicmomrebuilds

About

Legal